N

New York Medical College | Boston Children's Hospital - Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine

Research site

(Unclaimed)

Location

19 Bradhurst Avenue Suite 1400-South, Hawthorne, New York, United States of America

Site insights

Top conditions

Top treatments

Cytarabine

Dociparstat

VX-440

R-CHOP

Lorcaserin

Inotuzumab

Gemcitabine

Sodium Fusidate

Ozogamicin

Dupilumab

Parent organization

This site is a part of New York Medical College

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 26 total trials

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma (AIM4:Next Step)

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the air...

Enrolling

Asthma

Drug: dupilumab

Drug: Matching Placebo

Locations recently updated

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 and VX-828 in triple combination (TC) with Tezacaftor (T...

Enrolling

Cystic Fibrosis

Drug: Tezacaftor

Drug: VX-828

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta (PreciSION CF)

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SION-719 when given to people with CF wh...

Enrolling

Cystic Fibrosis (CF)

Drug: SION-719

Drug: Placebo-to-match SION-719